文献速递心脑血管急症复苏、休克与脓毒症

日本COVID-19疫情期间公众除颤与院外心脏骤停后良好神经功能结局

Public-access defibrillation and favorable neurological outcome after out-of-hospital cardiac arrest during the COVID-19 pandemic in Japan.
PubMed 文献 · Crit Care · 2022-10-31
一句话结论日本全国性注册研究显示,2020年公众除颤比例较2019年下降(AOR 0.86),但良好神经功能结局无显著下降(AOR 0.97)。

该研究基于日本全国院外心脏骤停(OHCA)注册数据库进行二次分析,纳入2005年1月1日至2020年12月31日期间年龄≥18岁、旁观者目击且初始节律为可除颤心律的OHCA患者。比较2019年与2020年数据,采用多因素logistic回归分析。结果显示,2020年公众除颤比例较2019年显著降低(AOR 0.86;95%CI 0.76-0.97),但良好神经功能结局(脑功能分级1或2)无显著下降(AOR 0.97;95%CI 0.87-1.07)。

要点

  • 2020年公众除颤比例为15.1%(735/4869),低于2019年的17.7%(876/4959),调整后AOR 0.86(95%CI 0.76-0.97)。
  • 2020年良好神经功能结局比例为22.8%(1109/4869),与2019年的25.1%(1245/4959)相比无显著下降,AOR 0.97(95%CI 0.87-1.07)。
  • 2005年至2019年间,公众除颤比例和良好神经功能结局比例均呈逐年上升趋势(P for trend < 0.001)。
  • 研究纳入旁观者目击且初始节律为可除颤心律的成年OHCA患者,2020年公众除颤比例下降可能与COVID-19疫情相关。

适用人群与场景

  • 年龄≥18岁、旁观者目击的院外心脏骤停(OHCA)患者,且初始心律为可除颤心律,于2005年1月1日至2020年12月31日期间被转运至医疗机构。

诊断标准与关键阈值

  • 良好神经功能结局定义为脑功能分级(cerebral performance category)评分为1或2。

研究设计与关键结果

  • 研究类型:基于全日本Utstein注册数据库(全国性、前瞻性、人群基础的OHCA注册)的二次分析。
  • 研究期间共注册1,930,273例OHCA患者,其中78,302例符合分析条件。
  • 2005年至2019年,公众除颤比例和良好神经功能结局比例均呈逐年上升趋势(P for trend < 0.001)。
  • 2019年公众除颤比例为17.7%(876/4959),2020年为15.1%(735/4869)。
  • 2019年良好神经功能结局比例为25.1%(1245/4959),2020年为22.8%(1109/4869)。
  • 多因素logistic回归分析显示,与2019年相比,2020年公众除颤比例显著降低(AOR 0.86;95%CI 0.76-0.97)。
  • 多因素logistic回归分析显示,与2019年相比,2020年良好神经功能结局无显著下降(AOR 0.97;95%CI 0.87-1.07)。

证据类型、等级与局限

  • 证据类型:基于全国性前瞻性注册数据库的二次分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,2020年公众除颤比例明显下降,可能由日本COVID-19疫情所致;但良好神经功能结局未观察到显著下降。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Early public-access defibrillation (PAD) effectively improves the outcomes of out-of-hospital cardiac arrests (OHCA), but several strategies implemented to prevent the spread of coronavirus disease 2019 (COVID-19) could decrease the availability of PAD and worsen outcomes after OHCA. Previous studies have reported conflicting findings, and there is a paucity of nationwide observations. This study aims to investigate the impact of COVID-19 on PAD and OHCA outcomes using a nationwide OHCA registry in Japan, where PAD is well-documented.

METHODS: This secondary analysis of the All-Japan Utstein Registry, a prospective population-based nationwide registry of OHCA patients, included patients aged ≥ 18 years with bystander-witnessed OHCA and an initial shockable rhythm who were transported to medical facilities between January 1, 2005, and December 31, 2020. The analytical parameters of this study were the proportion of patients who underwent PAD and patients with one-month survival with favorable neurological outcomes, defined as a cerebral performance category score of 1 or 2. We compared the data between 2019 and 2020 using a multivariable logistic regression analysis.

RESULTS: During the study period, 1,930,273 OHCA patients were registered; of these, 78,302 were eligible for the analysis. Before the COVID-19 pandemic, the proportion of OHCA patients who underwent PAD and demonstrated favorable neurological outcomes increased gradually from 2005 to 2019 (P for trend &lt; 0.001). The proportion of patient who had PAD were 17.7% (876/4959) in 2019 and 15.1% (735/4869) in 2020, respectively. The proportion of patient who displayed favorable neurological outcomes were 25.1% (1245/4959) in 2019 and 22.8% (1109/4869) in 2020, respectively. After adjusting for potential confounders, a significant reduction in the proportion of PAD was observed compared to that in 2019 (adjusted odds ratio [AOR], 0.86; 95% confidence interval [CI], 0.76-0.97), while no significant reduction was observed in favorable neurological outcomes (AOR, 0.97; 95% CI 0.87-1.07).

CONCLUSION: The proportion of PAD clearly decreased in 2020, probably due to the COVID-19 pandemic in Japan. In contrast, no significant reduction was observed in favorable neurological outcomes.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Matsuyama T, Kiyohara K, Kitamura T, et al. Public-access defibrillation and favorable neurological outcome after out-of-hospital cardiac arrest during the COVID-19 pandemic in Japan. Crit Care. 2022. PMID: 36316712. doi:10.1186/s13054-022-04220-9

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。